Search results for:
abatacept
abatacept
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Orencia IV |
POWDER FOR INJECTION, INTRAVENOUS |
250 mg |
|
|
|
|
| Orencia Subcutaneous |
SOLUTION, SUBCUTANEOUS |
125 mg/mL |
|
|
|
|
Last updated: Dec. 28, 2017
Orencia IV is restricted to use in Outpatient Medical Department. Defer inpatient orders to outpatient therapy whenever possible.
Orencia Subcutaneous is non-formulary, not stocked. Defer the dose until after discharge.
Reviewed: October 30, 2007 (Orencia IV) and December 13, 2011 (Orencia Subcutaneous)